← back to search

Constance H. Katelaris

Camden and Campbelltown Hospitals ·
Area of research
Immunology and Allergy · Physiology
Research interest
Research interests include Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Coagulation, Bradykinin, Polyphosphates, and Angioedema, and Food Allergy and Anaphylaxis Research.
h-index
49
citations
12,036
works
267
NIH funding
primary concept
email

Recent publications

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
Clinical Reviews in Allergy & Immunology 2025cited by 41position: middledoi
Unmet needs in hereditary angioedema: an international survey of physicians
Orphanet Journal of Rare Diseases 2025cited by 8position: middledoi
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor
Journal of Allergy and Clinical Immunology Global 2025cited by 7position: middledoi
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema
Allergy and Asthma Proceedings 2025cited by 7position: lastdoi
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
Clinical and Translational Allergy 2025cited by 2position: middledoi
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study
Allergy 2024cited by 25position: middledoi
Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma
European Respiratory Journal 2024cited by 18position: middledoi
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A <scp>CRUSE</scp> ® mobile health study
Allergy 2024cited by 10position: middledoi
The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
Clinical & Experimental Allergy 2024cited by 5position: middledoi
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Nature 2023cited by 102position: middledoi
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Allergy 2023cited by 84position: middledoi
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis
Allergy Asthma and Clinical Immunology 2023cited by 27position: middledoi
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
Journal of Allergy and Clinical Immunology 2023cited by 19position: middledoi
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Allergy 2022cited by 472position: middledoi
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
World Allergy Organization Journal 2022cited by 149position: middledoi
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction
Annals of Allergy Asthma & Immunology 2022cited by 14position: middledoi
Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond
The Journal of Allergy and Clinical Immunology In Practice 2022cited by 11position: middledoi
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 209position: middledoi
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
The Journal of Allergy and Clinical Immunology In Practice 2021cited by 144position: middledoi
Consensus on treatment goals in hereditary angioedema: A global Delphi initiative
Journal of Allergy and Clinical Immunology 2021cited by 66position: middledoi
The global burden of chronic urticaria for the patient and society*
British Journal of Dermatology 2020cited by 331position: middledoi
Mepolizumab effectiveness and identification of super-responders in severe asthma
European Respiratory Journal 2020cited by 191position: middledoi
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
Allergy 2020cited by 89position: middledoi
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis
Annals of Allergy Asthma & Immunology 2020cited by 81position: middledoi
Definition, aims, and implementation of GA<sup>2</sup>LEN/HAEi Angioedema Centers of Reference and Excellence
Allergy 2020cited by 56position: middledoi
Ligelizumab for Chronic Spontaneous Urticaria
New England Journal of Medicine 2019cited by 244position: middledoi
ICON
Annals of Allergy Asthma & Immunology 2019cited by 150position: middledoi
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 94position: middledoi
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 74position: middledoi
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Allergy 2018cited by 1,423position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Markus Magerl · Humboldt-Universität zu Berlin5 papers (2012–2025) · 3 papers (2019–2022)Jonathan A. Bernstein · ENT and Allergy3 papers (2020–2024)William R. Lumry · The University of Texas Southwestern Medical Center3 papers (2012–2025)Marcus Maurer · McGill University3 papers (2012–2021)Jonathan Corren · APLA Health2 papers (2019–2020)Nicola A. Hanania · Baylor College of Medicine2 papers (2020–2022)Ruby Pawankar · University of Aberdeen2 papers (2012–2016) · 2 papers (2012–2021) · 2 papers (2020–2021)Mar Guilarte · Hebron University2 papers (2024–2025)Mario Castro · University of Kansas Medical Center2 papers (2019–2022)Aleena Banerji · Harvard University2 papers (2021–2023)William W. Busse · University of Wisconsin–Madison2 papers (2019–2020)Paula J. Busse · Humboldt-Universität zu Berlin2 papers (2021–2023)Paul K. Keith · Johannes Gutenberg University Mainz2 papers (2023–2024)Bruce L. Zuraw · La Jolla Institute for Immunology2 papers (2012–2021) · 2 papers (2019–2020)Timothy Craig · Johannes Gutenberg University Mainz2 papers (2012–2021)Sivan Harel · Columbia University2 papers (2019–2020)